Investors Cozy Up to Danish Stocks - The New York Times
Investors await Novo Nordisk's diabetes pill
Contact investor relations
Revisiting Novo Nordisk (NYSE:NVO) | Seeking Alpha
Novo Nordisk HQ sells for 305M to Korean investment firm top single-asset sale of 2016 - NJBIZ
Novo Nordisk investing $117.4M in manufacturing site in Denmark | FiercePharma
Novo Nordisk plans new investments in Denmark - The Local
Novo Nordisk unveils £115m UK pharma investment, but Brexit is still destroying jobs | The Independent | The Independent
Financial results and events
Investors - NBE Therapeutics
Novo Nordisk to continue investing in Bangladesh to fight diabetes | The Daily Star
Novo Nordisk A focused healthcare company
Financial results and events
Novo Nordisk announces another $22M investment in Clayton - Triangle Business Journal
Novo Nordisk owners launch impact investment fund
Prepared by Imprima de Bussy
South Korean AIP Makes Their First Investment in Denmark % AIP ASSET MANAGEMENT
Investors
Investors angry about insulin woes sue Novo Nordisk in Denmark for $1.75B | FiercePharma
Novo Nordisk - Crunchbase Company Profile & Funding
Novo Nordisk 0 A focused healthcare company Investor presentation – Merrill Lynch Global Pharmaceutical Conference London, 24 September ppt download
Novo Nordisk (NVO) Investor Presentation - Slideshow (NYSE:NVO) | Seeking Alpha
